ProfoundBio is an oncology biotherapeutics company.
ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 2, 2022 | Series A | $70M | 1 | — | — | Detail |
Jul 12, 2021 | Series A | $55M | 2 | Lilly Asia Ventures | — | Detail |
Feb 8, 2021 | Seed | $10M | 2 | Xianfeng Qiyun | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Xianfeng Qiyun | Yes | Seed |
Lilly Asia Ventures | — | Series A |
Gaorong Capital | — | Series A |